Back to Results
First PageMeta Content
SEC filings / Health / Watson Pharmaceuticals / Regulation S-K / Pharmaceutical industry / Food and Drug Administration / Novartis / Generic drug / Barr Pharmaceuticals / Pharmaceutical sciences / Pharmacology / Pharmaceuticals policy


Document Date: 2009-03-20 13:38:41

Open Document

File Size: 730,45 KB

Share Result on Facebook

City

Salt Lake City / Corona / Mumbai / Copiague / Ambernath / New York / Changzhou City / /

Company

BUSINESS Business Overview Watson Pharmaceuticals Inc. / Schein Pharmaceutical Inc. / K WATSON PHARMACEUTICALS INC / Shionogi & Co. Ltd. / Watson Pharma / GlaxoSmithKline / New York Stock Exchange / Barr Pharmaceuticals Inc. / Cephalon Inc. / Unimed Pharmaceuticals Inc. / Sciele Pharma Inc. / Watson Laboratories / WATSON PHARMACEUTICALS INC. / Solvay Pharmaceuticals Inc. / Novartis AG / Which Registered New York Stock Exchange Securities / Teva Pharmaceutical Industries Ltd. / Sandoz Pharmaceutical Corporation / /

Country

India / Taiwan / United States / /

Currency

USD / /

Event

M&A / Funding / General or Shareholder Meeting / Legal Issues / /

Facility

DEPOT Trelstar / India facility / New York facility / /

IndustryTerm

selected products / owned subsidiary / generic pharmaceutical product families / dosage manufacturing / generic prescription products / Internet website / pharmaceutical businesses / product manufacturing / generic pharmaceuticals / pharmaceuticals / quality generic products / in-house technologies / over-the-counter generic products / alternative to brand products / manufacturing / differentiated and high demand products / brand pharmaceuticals / brand pharmaceutical product families / Internet website address / Generic pharmaceutical products / respective brand products / food store chains / manufacturing sites / retail drug / generic alternatives to our brand products / pharmaceutical / sustained-release and other drug delivery technologies / brand pharmaceutical products / development-stage products / treatment of Alzheimer’s disease / pharmaceutical product families / drug delivery technologies / manufacturing operations / pharmaceutical products / off-patent trademarked products / generic products / /

MedicalCondition

Therapeutic Classification Osteoporosis / active duodenal ulcer / cancer / vomiting / nausea / Alzheimer’s disease / /

MedicalTreatment

chemotherapy / hormone replacement / /

Organization

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington / D.C. / U.S. Securities and Exchange Commission / officers of the Registrant Executive Compensation Security Ownership / U.S. Food and Drug Administration / I.R.S. / /

Person

Weston / Davie / /

/

Position

physician / DIRECTOR INDEPENDENCE / leader in the development / /

Product

Fosamax / acetaminophen / Ovral / Duragesic / cyclosporine / Cardizem / Alendronate Sodium / AndroGel / Low-Ogestrel / Zyban / Nordette / Wellbutrin XL / galantamine hydrobromide / HCI tablets / Cenestin / fentanyl citrate / Nicotine polacrilex / Percocet / Trelstar / Ortho-Novum / Fentanyl / Modicon / Iron dextran / Nicorette / metoclopramide / desmopressin acetate / Glucotrol / Microgestin / mirtazapine / Wellbutrin SR / Biaxin / Triphasil / Cartia XT / metoprolol succinate / Fortamet / Bupropion hydrochloride / Levora / Loestrin / Antiemetic Analgesic / Ortho Tri-Cyclen / Norco / Clarithromycin / Androderm / Omeprazole / Vicodin / Marinol / Lortab / Glipizide / Oxytrol / Ferrlecit / XL 150mg / Trivora / Prilosec / Testosterone / INFeD / Altoprev / Alesse / /

ProvinceOrState

New York / Utah / California / Goa / Florida / Nevada / /

Technology

in-house technologies / chemotherapy / drug delivery technologies / /

URL

www.sec.gov / www.watson.com / /

SocialTag